section name header

Y-Site Injection Compatibility (1:1 Mixture)

Blinatumomab

(Mfr: AMG)(Conc: 0.125 and 0.375 mcg/mLb)

QMark

Imipenem-cilastatin sodium

(Mfr: PAN)(Conc: 5 mg/mLb,c)

Remarks:

Particles, flakes, thin needles, or haze transiently appears when blinatumomab is added to imipenem-cilastatin; not observed when order of mixing was reversed

Ref:

3405,3417